Effectiveness and Safety of Recombinant Zoster Vaccine in Rheumatic Diseases: Real-World Evidence from a Single-Centre Italian Cohort
RZV displayed an effective and reassuring safety profile in a heterogeneous cohort of patients affected by RMDs, irrespective of the diagnosis and the ongoing therapy. This supports the broader use of RZV as a safe and valuable preventive strategy in patients with RMDs.
Authors
- Caterina Baldi (ORCID: https://orcid.org/0000-0002-3070-5568)
- Bruno Frediani (ORCID: https://orcid.org/0000-0002-9375-5984)
- Emilio D’Ignazio (ORCID: https://orcid.org/0000-0002-1033-9695)
- Estrella Garcia Gonzalez (ORCID: https://orcid.org/0000-0001-5906-4891)
- Francesca Bellisai
- Enrico Selvi
- Paolo Falsetti (ORCID: https://orcid.org/0000-0003-2667-4866)
- Luca Cantarini (ORCID: https://orcid.org/0000-0002-7352-1275)
- Edoardo Conticini (ORCID: https://orcid.org/0000-0002-3974-6606)
- Stefano Gentileschi (ORCID: https://orcid.org/0000-0001-6658-1037)
- Marco Bardelli (ORCID: https://orcid.org/0000-0003-1893-0401)
- Jurgen Sota (ORCID: https://orcid.org/0000-0002-7549-2922)
- Irene Fineschi
- Sara Valentini (ORCID: https://orcid.org/0009-0001-3897-7226)
- Marta Fabbroni
Institutions
- University of Siena (IT)
- Azienda Usl 8 Arezzo (IT)
Publication Details
- Journal
- Vaccines
- Published
- 2025-12-05
- DOI
- https://doi.org/10.3390/vaccines13121227
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00